SIMPLEX TRADING, LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$0
-100.0%
200
-98.3%
0.00%
Q2 2019$72,000
+176.9%
11,707
+108.4%
0.00%
Q1 2019$26,000
-7.1%
5,618
+25.6%
0.00%
Q3 2018$28,000
+75.0%
4,473
+116.9%
0.00%
Q2 2018$16,000
-90.1%
2,062
-90.5%
0.00%
-100.0%
Q1 2018$162,000
+74.2%
21,754
+38.5%
0.01%
+75.0%
Q4 2017$93,000
-48.9%
15,710
-36.7%
0.00%
-42.9%
Q3 2017$182,000
+1113.3%
24,812
+994.0%
0.01%
+600.0%
Q2 2017$15,000
+275.0%
2,268
+338.7%
0.00%
Q4 2016$4,000
-83.3%
517
-86.9%
0.00%
-100.0%
Q3 2016$24,000
-7.7%
3,942
-34.5%
0.00%0.0%
Q1 2016$26,000
+23.8%
6,018
+71.5%
0.00%0.0%
Q4 2015$21,0003,509
+5382.8%
0.00%
Q3 2015$0
-100.0%
64
-96.8%
0.00%
-100.0%
Q2 2015$14,000
-30.0%
2,010
-41.8%
0.00%
-50.0%
Q1 2015$20,0003,4550.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 8,951,169$54,871,0003.38%
Virtus ETF Advisers LLC 103,807$636,0001.75%
BKS ADVISORS, LLC 291,150$1,785,0000.92%
Piermont Capital Management Inc. 363,549$2,229,0000.71%
TUDOR INVESTMENT CORP ET AL 2,370,760$14,532,0000.41%
SEARLE & CO. 60,000$349,0000.34%
TURNER INVESTMENTS LLC 252,785$1,550,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 891,672$5,466,0000.31%
Phocas Financial Corp. 635,333$3,895,0000.30%
TFS CAPITAL LLC 398,283$2,441,0000.26%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders